Cogent (CCOI) Q2 2025 Earnings Call Transcript

Cogent reported Q2 revenue of $246.2 million, with the sequential decline slowing sharply to $800,000 from $5.2 million last quarter, while adjusted EBITDA rose 7% sequentially to $73.5 million and margin expanded 200 bps to 29.8%. Wavelength revenue jumped 27% sequentially and 150% year over year to $9.1 million, supported by a 4,687-opportunity funnel and management's reiterated $500 million run-rate target by mid-2028. The company also extended liquidity via a $600 million 2032 secured note and a $174.4 million IPv4 securitization, while increasing the quarterly dividend and authorizing an additional $100 million buyback.

Analysis

CCOI is finally transitioning from a balance-sheet story to a throughput story, but the market is likely still underestimating how lumpy that inflection will be. The key second-order effect is that wavelength is acting like a call option on the existing customer base: most early demand is coming from already-embedded transit accounts, which means the near-term win rate is less about new-logo selling and more about monetizing an installed relationship base faster than competitors can respond. That favors CCOI's salesforce efficiency and pricing power, while it pressures legacy carriers with slower provisioning and weaker service consistency.

The bigger medium-term driver is mix, not volume. If the company keeps migrating revenue away from low-return off-net and Sprint-era residue into on-net IP and wavelength, EBITDA can expand even if reported revenue grows only modestly in the next couple quarters. That creates a powerful denominator effect for leverage, but investors should be careful: the company is still carrying a high fixed-cost and capital-return burden, so any stumble in wavelength billing conversion or CapEx timing could delay the deleveraging narrative by 1-2 quarters.

The most interesting contrarian angle is that the market may be too focused on the optics of billing lag and too little on the operational learning curve. Several hundred installed-but-unbilled wavelengths is not a demand problem; it is evidence that provisioning is outrunning customer readiness, which is exactly what happens when a new entrant gains credibility. The risk is that management's aggressive market-share framing invites skepticism until the billable base becomes large enough to smooth the cadence; if conversion stalls, the stock could de-rate quickly on fears the growth is being pulled forward rather than created.

Capital returns remain supportive, but not without tension. Buybacks and dividend growth are workable only if the company executes on EBITDA expansion and keeps CapEx contained; otherwise, the equity market may start treating shareholder returns as balance-sheet leakage rather than discipline. Over the next 3-6 months, the stock should trade more on evidence of sequential billable wave conversion and margin flow-through than on headline revenue growth alone.

Key Decisions for Investors

• Long CCOI for 3-6 months on pullbacks: attractive if the market keeps discounting the billing lag; upside comes from sequential revenue inflection plus margin expansion, while downside is capped if deleveraging stays on track.
• Buy CCOI call spreads into the next 1-2 earnings prints (e.g., 6-9 month tenor): best risk/reward if waves convert from installed-but-unbilled to billed faster than consensus expects; limit premium paid because execution remains lumpy.
• Pair trade: long CCOI / short a slower-growth legacy telecom or bandwidth peer with weaker mix and higher leverage over the next 2-4 quarters; thesis is mix improvement and capital intensity differentiation, not absolute industry growth.
• Fade any sharp rally above near-term resistance if billable wave conversions do not accelerate: the market may temporarily overprice the $500M wavelength runway before the billing cadence proves it is repeatable.
• Monitor credit spreads on CCOI debt over the next 30-90 days: if bonds tighten while equity stalls, that is a cleaner signal that the market believes the deleveraging path is real even if the stock remains range-bound.